Page last updated: 2024-11-06

mitomycin and Thymoma

mitomycin has been researched along with Thymoma in 4 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hama-Inaba, H1
Wang, B1
Mori, M1
Matsushima, T1
Saitoh, T1
Takusagawa, M1
Yamada, T1
Muto, M1
Ohyama, H1
Kataoka, T1
Ito, M1
Budd, RC1
Tschopp, J1
Nagai, K1
Ujiie, T1
Ryoyama, K1
Ryoyama, C1

Other Studies

4 other studies available for mitomycin and Thymoma

ArticleYear
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
    Mutation research, 1998, Jul-17, Volume: 403, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl

1998
Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
    Experimental cell research, 2002, Feb-15, Volume: 273, Issue:2

    Topics: Animals; Apoptosis; Camptothecin; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein

2002
Immunogenic potential of tumor cells after treatment with antitumor chemotherapeutic agents.
    The Japanese journal of experimental medicine, 1988, Volume: 58, Issue:1

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Cyto

1988
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.
    Cancer immunology, immunotherapy : CII, 1989, Volume: 29, Issue:4

    Topics: Animals; Cyclophosphamide; Dose-Response Relationship, Drug; Immunity, Cellular; Immunotherapy; In V

1989